Nonalcoholic fatty liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic standard of the nonalcoholic fatty liver disease; 2. Meet the standard of Wet-stasis syndrome; 3. Aged 18-65 years old; 4. ALT is greater than the upper limit of normal (male> 50IU / L, female> 40 IU / L), and less than or equal to 5 times the upper limit of normal; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who have used other liver-protecting and enzyme-lowering drugs which might affect the efficacy evaluation in the past 3 months; 2. Patients with alcoholic fatty liver (male alcohol intake> 20g / d, female alcohol intake> 10g / d);Patients with cirrhosis, HBV, HCV and other liver diseases; Patients with autoimmune liver disease; People who are taking any drug which might cause fatty liver; 3. Those with normal liver function; 4. Those who have undergone gastrointestinal weight loss surgery in the past year or those who have lost weight by more than 10% after taking weight-loss drugs within the past 3 months; 5. Pregnant women, lactating women, patients with primary diseases such as cardiovascular, lung, kidney, hematopoietic system, and other major diseases such as malignant tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRI-PDFF;serum activity of ALT; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum activity of GGT;waistline;serum levels of LDL;SF-36;Abdominal Fibroscan CAP;TCM Syndrome Points;fasting blood-glucose;serum levels of TG;insulin resistance index;serum levels of HDL-C;fasting insulin;serum levels of TC;BMI;serum activity of AST;weight; | — |
Countries
China